(Q53568084)

15 May 2018

title

Deleterious effects of lack of cardiac PAI-1 after coronary occlusion in mice and their pathophysiologic determinants. (English)

1 reference

15 May 2018

1 reference

1 reference

A K M Tarikuz Zaman

1

1 reference

15 May 2018

Satoshi Fujii

2

1 reference

15 May 2018

David J Schneider

3

1 reference

15 May 2018

Douglas J Taatjes

4

1 reference

15 May 2018

H Roger Lijnen

5

1 reference

15 May 2018

Burton E Sobel

6

1 reference

15 May 2018

publication date

19 June 2007

1 reference

15 May 2018

Histochemistry and Cell Biology

published in

1 reference

15 May 2018

volume

128

1 reference

15 May 2018

issue

2

1 reference

15 May 2018

page(s)

135-145

1 reference

15 May 2018

https://scigraph.springernature.com/pub.10.1007/s00418-007-0300-z

exact match

0 references

cites work

Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery.

1 reference

https://api.crossref.org/works/10.1007%2FS00418-007-0300-Z

Factors influencing infarct size following experimental coronary artery occlusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-007-0300-Z

Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-007-0300-Z

Induction of plasminogen activator inhibitor type-1 (PAI-1) by proinsulin and insulin in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-007-0300-Z

An improved basis for enzymatic estimation of infarct size

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-007-0300-Z

Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients: a potential factor predisposing to thrombosis and its persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-007-0300-Z

Increased expression of plasminogen activator inhibitor-1 in cardiomyocytes contributes to cardiac fibrosis after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-007-0300-Z

Angiotensin-converting enzyme inhibition attenuates hypofibrinolysis and reduces cardiac perivascular fibrosis in genetically obese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-007-0300-Z

Abnormal myocardial acoustic properties in diabetic patients and their correlation with the severity of disease

21 January 2018

1 reference

12 December 2020

Overexpression of mitochondrial peroxiredoxin-3 prevents left ventricular remodeling and failure after myocardial infarction in mice

1 reference

12 December 2020

Collagen remodelling in myocardia of patients with diabetes

1 reference

12 December 2020

Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition

1 reference

12 December 2020

The role of plasminogen activator inhibitor type 1 in the inflammatory response to local tissue injury

1 reference

12 December 2020

Prognosis following first acute myocardial infarction in Type 2 diabetes: a comparative population study

1 reference

12 December 2020

Augmentation of proliferation of vascular smooth muscle cells by plasminogen activator inhibitor type 1.

1 reference

12 December 2020

Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model

1 reference

12 December 2020

Myeloperoxidase and plasminogen activator inhibitor 1 play a central role in ventricular remodeling after myocardial infarction

1 reference

12 December 2020

Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse

1 reference

12 December 2020

Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene

1 reference

12 December 2020

Modifications of a specific assay for hydroxyproline in urine

1 reference

12 December 2020

Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery

1 reference

12 December 2020

Quantitative analysis of atherosclerotic lesion composition in mice

1 reference

12 December 2020

Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization

1 reference

12 December 2020

Indication of a role of plasminogen activator inhibitor type I in protecting murine fibrosarcoma cells against apoptosis

1 reference

12 December 2020

Insulin resistance increases PAI-1 in the heart

1 reference

12 December 2020

The urokinase receptor mediates basic fibroblast growth factor-dependent smooth muscle cell migration through baboon aortic explants

1 reference

12 December 2020

Plasminogen activation: a mediator of vascular smooth muscle cell apoptosis in atherosclerotic plaques

1 reference

12 December 2020

Intramural plasminogen activator inhibitor type-1 and coronary atherosclerosis

1 reference

12 December 2020

Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition

1 reference

12 December 2020

Depressed Myocardial Creatine Phosphokinase Activity Following Experimental Myocardial Infarction in Rabbit

1 reference

12 December 2020

Design, synthesis and in vitro evaluation of potent, novel, small molecule inhibitors of plasminogen activator inhibitor-1

1 reference

12 December 2020

Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer

1 reference

12 December 2020

Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients

1 reference

12 December 2020

Increased plasminogen activator inhibitor type-1 (PAI-1) in the heart as a function of age.

1 reference

12 December 2020

Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells

1 reference

12 December 2020

The potential influence of insulin and plasminogen activator inhibitor type 1 on the formation of vulnerable atherosclerotic plaques associated with type 2 diabetes.

1 reference

12 December 2020

Salutary effects of attenuation of angiotensin II on coronary perivascular fibrosis associated with insulin resistance and obesity

1 reference

12 December 2020

Myocardial infarct size and mortality in diabetic patients

1 reference

12 December 2020

Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk

1 reference

12 December 2020

Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activity

1 reference

12 December 2020

Adaptation and maladaptation of the heart in diabetes: Part II: potential mechanisms

1 reference

12 December 2020

Renal fibrosis: not just PAI-1 in the sky.

1 reference

12 December 2020

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

12 December 2020

Early Estimation of Myocardial Damage in Conscious Dogs and Patients with Evolving Acute Myocardial Infarction

1 reference

12 December 2020

Anti-Monocyte Chemoattractant Protein-1 Gene Therapy Attenuates Left Ventricular Remodeling and Failure After Experimental Myocardial Infarction

1 reference

12 December 2020

Postmyocardial infarction patients: experience from the SAVE trial.

1 reference

12 December 2020

Plasminogen activator inhibitor-1 impairs plasminogen activation-mediated vascular smooth muscle cell apoptosis

1 reference

12 December 2020

Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor beta

1 reference

12 December 2020

Attenuation of neointimal vascular smooth muscle cellularity in atheroma by plasminogen activator inhibitor type 1 (PAI-1).

1 reference

12 December 2020

Attenuation of accumulation of neointimal lipid by pioglitazone in mice genetically deficient in insulin receptor substrate-2 and apolipoprotein E.

1 reference

12 December 2020

An improved procedure for serum creatine phosphokinase determination

1 reference

12 December 2020

Altered myocardial function and collagen in diabetic rhesus monkeys on atherogenic diet

1 reference

12 December 2020

Inhibition of apoptosis and caspase-3 in vascular smooth muscle cells by plasminogen activator inhibitor type-1.

1 reference

12 December 2020

10.1007/S00418-007-0300-Z

Identifiers

DOI

1 reference

15 May 2018

release_izydemr6jra6rolophnorpkqja

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/izydemr6jra6rolophnorpkqja

24 November 2022

mapped directly with Wikidata item

1 reference

15 May 2018